Interdependence of kallikrein-related peptidases in proteolytic networks

Biological Chemistry

Volumn 391, Issue 5, 2010, Pages 581-587

  Beaufort, Nathalie ^a   Plaza, Karolina ^a,b   Utzschneider, Daniel ^a   Schwarz, Amelie ^a   Burkhart, Julia M ^a   Creutzburg, Sabine ^a   Debela, Mekdes ^a,c,e   Schmitt, Manfred ^a   Ries, Christian ^d   Magdolen, Viktor ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Cancer; Matrix metalloproteinases; Proteases; Urokinase; Zymogen activation

Indexed keywords

ENZYME PRECURSOR; KALLIKREIN 6; KALLIKREIN RELATED PEPTIDASE; PEPTIDASE; STROMELYSIN; TRYPSIN; UNCLASSIFIED DRUG; UROKINASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION;

ENZYME ACTIVATION; ENZYME PRECURSORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; KALLIKREINS; MATRIX METALLOPROTEINASE 3; NEOPLASMS; SERINE ENDOPEPTIDASES; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 77952845312     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2010.055     Document Type: Article

References (31)

1. Barrett, A.J. (2004). Bioinformatics of proteases in the MEROPS database. Curr. Opin. Drug Discov. Dev. 7, 334-341.
2. Beaufort, N., Debela, M., Creutzburg, S., Kellermann, J., Bode, W., Schmitt, M., Pidard, D., and Magdolen, V. (2006). Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR). Biol. Chem. 387, 217-222.
3. Becker-Pauly, C., Howel, M., Walker, T., Vlad, A., Aufenvenne, K., Oji, V., Lottaz, D., Sterchi, E.E., Debela, M., Magdolen, V., et al. (2007). The a and b subunits of the metalloprotease meprin are expressed in separate layers of human epidermis, revealing different functions in keratinocyte proliferation and differentiation. J. Invest. Dermatol. 127, 1115-1125.
4. Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876-890.
5. Dano, K., Behrendt, N., Hoyer-Hansen, G., Johnsen, M., Lund, L.R., Ploug, M., and Romer, J. (2005). Plasminogen activation and cancer. Thromb. Haemost. 93, 676-681.
6. Debela, M., Magdolen, V., Grimminger, V., Sommerhoff, C., Messerschmidt, A., Huber, R., Friedrich, R., Bode, W., and Goettig, P. (2006a). Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site. J. Mol. Biol. 362, 1094-1107.
7. Debela, M., Magdolen, V., Schechter, N., Valachova, M., Lottspeich, F., Craik, C.S., Choe, Y., Bode, W., and Goettig, P. (2006b). Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences. J. Biol. Chem. 281, 25678-25688.
8. Debela, M., Goettig, P., Magdolen, V., Huber, R., Schechter, N.M., and Bode, W. (2007). Structural basis of the zinc inhibition of human tissue kallikrein 5. J. Mol. Biol. 373, 1017-1031.
9. Debela, M., Beaufort, N., Magdolen, V., Schechter, N.M., Craik, C.S., Schmitt, M., Bode, W., and Goettig, P. (2008). Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7. Biol. Chem. 389, 623-632.
10. Emami, N. and Diamandis, E.P. (2010). Potential role of multiple members of the kallikrein-related peptidase family of serine proteases in activating latent TGFb1 in semen. Biol. Chem. 391, 85-95.
11. Freije, J.M., Balbin, M., Pendas, A.M., Sanchez, L.M., Puente, X.S., and Lopez-Otin, C. (2003). Matrix metalloproteinases and tumor progression. Adv. Exp. Med. Biol. 532, 91-107.
12. Frenette, G., Tremblay, R.R., Lazure, C., and Dube, J.Y. (1997). Prostatic kallikrein hK2, but not prostate-specific antigen (hK3), activates single-chain urokinase-type plasminogen activator. Int. J. Cancer 71, 897-899.
13. Gomis-Rüth, F.X., Bayés, A., Sotiropoulou, G., Pampalakis, G., Tsetsenis, T., Villegas, V., Avilés, F.X., and Coll, M. (2002). The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family. J. Biol. Chem. 277, 27273-27281.
14. Hollenberg, M.D., Oikonomopoulou, K., Hansen, K.K., Saifeddine, M., Ramachandran, R., and Diamandis, E.P. (2008). Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer. Biol. Chem. 389, 643-651.
15. Itoh, Y. and Nagase, H. (2002). Matrix metalloproteinases in cancer. Essays Biochem. 38, 21-36.
16. Jung, K., Nowak, L., Lein, M., Priem, F., Schnorr, D., and Loening, S.A. (1997). Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/ tissue inhibitor in plasma of patients with prostate cancer. Int. J. Cancer 74, 220-223.
17. Lopez-Otin, C. and Bond, J.S. (2008). Proteases: multifunctional enzymes in life and disease. J. Biol. Chem. 283, 30433-30437.
18. Ohler, A., Debela, M., Wagner, S., Magdolen, V., and Becker-Pauly, C. (2010). Analyzing the protease web in skin: meprin metalloproteases are activated specifically by KLK4, 5 and 8 vice versa leading to processing of proKLK7 thereby triggering its activation. Biol. Chem. 391, 455-460.
19. Pampalakis, G. and Sotiropoulou, G. (2007). Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer. Biochim. Biophys. Acta 1776, 22-31.
20. Ramsay, A.J., Dong, Y., Hunt, M.L., Linn, M., Samaratunga, H., Clements, J.A., and Hooper, J.D. (2008). Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression. J. Biol. Chem. 283, 12293-12304.
21. Ries, C., Pitsch, T., Mentele, R., Zahler, S., Egea, V., Nagase, H., and Jochum, M. (2007). Identification of a novel 82 kDa proMMP-9 species associated with the surface of leukaemic cells: (auto-)catalytic activation and resistance to inhibition by TIMP-1. Biochem. J. 405, 547-558.
22. Rittenhouse, H.G., Finlay, J.A., Mikolajczyk, S.D., and Partin, A.W. (1998). Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit. Rev. Clin. Lab. Sci. 35, 275-368.
23. Ryu, O., Hu, J.C., Yamakoshi, Y., Villemain, J.L., Cao, X., Zhang, C., Bartlett, J.D., and Simmer, J.P. (2002). Porcine kallikrein-4 activation, glycosylation, activity, and expression in prokaryotic and eukaryotic hosts. Eur. J. Oral Sci. 110, 358-365.
24. Shaw, J.L. and Diamandis, E.P. (2007). Distribution of 15 human kallikreins in tissues and biological fluids. Clin. Chem. 53, 1423-1432.
25. Sperl, S., Mueller, M.M., Wilhelm, O.G., Schmitt, M., Magdolen, V., and Moroder, L. (2001). The uPA/uPA receptor system as a target for tumor therapy. Drug News Perspect. 14, 401-411.
26. Takayama, T.K., Fujikawa, K., and Davie, E.W. (1997). Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. J. Biol. Chem. 272, 21582-21588. (Pubitemid 27374034)
27. Takayama, T.K., McMullen, B.A., Nelson, P.S., Matsumura, M., and Fujikawa, K. (2001). Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase. Biochemistry 40, 15341-15348.
28. Tye, C.E., Pham, C.T., Simmer, J.P., and Bartlett, J.D. (2009). DPPI may activate KLK4 during enamel formation. J. Dent. Res. 88, 323-327.
29. Yoon, H., Laxmikanthan, G., Lee, J., Blaber, S.I., Rodriguez, A., Kogot, J.M., Scarisbrick, I.A., and Blaber, M. (2007). Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J. Biol. Chem. 282, 31852-31864.
30. Yoon, H., Blaber, S.I., Evans, D.M., Trim, J., Juliano, M.A., Scarisbrick, I.A., and Blaber, M. (2008). Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis. Protein Sci. 17, 1998-2007.
31. Yoon, H., Blaber, S.I., Debela, M., Goettig, P., Scarisbrick, I.A., and Blaber, M. (2009). A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15. Biol. Chem. 390, 373-377.